nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—SLC22A5—Niacin—atherosclerosis	0.288	0.415	CbGbCtD
Ipratropium bromide—CYP2D6—Niacin—atherosclerosis	0.069	0.0991	CbGbCtD
Ipratropium bromide—CYP2D6—Simvastatin—atherosclerosis	0.0545	0.0784	CbGbCtD
Ipratropium bromide—CYP2D6—Pravastatin—atherosclerosis	0.0534	0.0767	CbGbCtD
Ipratropium bromide—CYP2D6—Lovastatin—atherosclerosis	0.0534	0.0767	CbGbCtD
Ipratropium bromide—CYP3A4—Rosuvastatin—atherosclerosis	0.0373	0.0536	CbGbCtD
Ipratropium bromide—CYP3A4—Ezetimibe—atherosclerosis	0.0373	0.0536	CbGbCtD
Ipratropium bromide—CYP3A4—Simvastatin—atherosclerosis	0.0347	0.0498	CbGbCtD
Ipratropium bromide—CYP3A4—Pravastatin—atherosclerosis	0.0339	0.0488	CbGbCtD
Ipratropium bromide—CYP3A4—Lovastatin—atherosclerosis	0.0339	0.0488	CbGbCtD
Ipratropium bromide—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00133	0.00581	CcSEcCtD
Ipratropium bromide—Arthritis—Niacin—atherosclerosis	0.00133	0.00581	CcSEcCtD
Ipratropium bromide—Arthritis—Pravastatin—atherosclerosis	0.00131	0.00572	CcSEcCtD
Ipratropium bromide—Influenza—Lovastatin—atherosclerosis	0.0013	0.00568	CcSEcCtD
Ipratropium bromide—Sinusitis—Rosuvastatin—atherosclerosis	0.00128	0.00561	CcSEcCtD
Ipratropium bromide—Influenza—Ezetimibe—atherosclerosis	0.00127	0.00558	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Lovastatin—atherosclerosis	0.00124	0.00545	CcSEcCtD
Ipratropium bromide—Rhinitis—Rosuvastatin—atherosclerosis	0.00123	0.00538	CcSEcCtD
Ipratropium bromide—Urinary retention—Niacin—atherosclerosis	0.00123	0.00537	CcSEcCtD
Ipratropium bromide—Pharyngitis—Rosuvastatin—atherosclerosis	0.00122	0.00533	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.00118	0.00518	CcSEcCtD
Ipratropium bromide—Bronchitis—Simvastatin—atherosclerosis	0.00117	0.00511	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Simvastatin—atherosclerosis	0.00116	0.0051	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00113	0.00497	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00113	0.00494	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Lovastatin—atherosclerosis	0.00112	0.00493	CcSEcCtD
Ipratropium bromide—Influenza—Niacin—atherosclerosis	0.00111	0.00488	CcSEcCtD
Ipratropium bromide—Dysphagia—Niacin—atherosclerosis	0.00111	0.00488	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00111	0.00487	CcSEcCtD
Ipratropium bromide—Influenza—Pravastatin—atherosclerosis	0.0011	0.00481	CcSEcCtD
Ipratropium bromide—Sinusitis—Lovastatin—atherosclerosis	0.00109	0.00476	CcSEcCtD
Ipratropium bromide—Bronchitis—Niacin—atherosclerosis	0.00107	0.0047	CcSEcCtD
Ipratropium bromide—Sinusitis—Ezetimibe—atherosclerosis	0.00106	0.00466	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00106	0.00465	CcSEcCtD
Ipratropium bromide—Flatulence—Rosuvastatin—atherosclerosis	0.00105	0.00461	CcSEcCtD
Ipratropium bromide—Dysuria—Pravastatin—atherosclerosis	0.00103	0.00449	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00102	0.00447	CcSEcCtD
Ipratropium bromide—Sinusitis—Simvastatin—atherosclerosis	0.00102	0.00445	CcSEcCtD
Ipratropium bromide—Pharyngitis—Ezetimibe—atherosclerosis	0.00101	0.00443	CcSEcCtD
Ipratropium bromide—Angioedema—Rosuvastatin—atherosclerosis	0.000975	0.00427	CcSEcCtD
Ipratropium bromide—Stomatitis—Niacin—atherosclerosis	0.000969	0.00424	CcSEcCtD
Ipratropium bromide—Flushing—Lovastatin—atherosclerosis	0.000964	0.00422	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000959	0.0042	CcSEcCtD
Ipratropium bromide—Sweating—Niacin—atherosclerosis	0.000953	0.00417	CcSEcCtD
Ipratropium bromide—Urinary tract infection—Pravastatin—atherosclerosis	0.000951	0.00417	CcSEcCtD
Ipratropium bromide—Flushing—Ezetimibe—atherosclerosis	0.000946	0.00414	CcSEcCtD
Ipratropium bromide—Cough—Rosuvastatin—atherosclerosis	0.000931	0.00408	CcSEcCtD
Ipratropium bromide—Immune system disorder—Ezetimibe—atherosclerosis	0.00092	0.00403	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000918	0.00402	CcSEcCtD
Ipratropium bromide—Sinusitis—Pravastatin—atherosclerosis	0.000918	0.00402	CcSEcCtD
Ipratropium bromide—Myalgia—Rosuvastatin—atherosclerosis	0.000908	0.00398	CcSEcCtD
Ipratropium bromide—Flushing—Simvastatin—atherosclerosis	0.000902	0.00395	CcSEcCtD
Ipratropium bromide—Haemoglobin—Niacin—atherosclerosis	0.000897	0.00393	CcSEcCtD
Ipratropium bromide—Rhinitis—Niacin—atherosclerosis	0.000894	0.00392	CcSEcCtD
Ipratropium bromide—Haemorrhage—Niacin—atherosclerosis	0.000892	0.00391	CcSEcCtD
Ipratropium bromide—Flatulence—Lovastatin—atherosclerosis	0.000891	0.0039	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Niacin—atherosclerosis	0.000888	0.00389	CcSEcCtD
Ipratropium bromide—Dysgeusia—Lovastatin—atherosclerosis	0.000886	0.00388	CcSEcCtD
Ipratropium bromide—Rhinitis—Pravastatin—atherosclerosis	0.000881	0.00386	CcSEcCtD
Ipratropium bromide—Back pain—Lovastatin—atherosclerosis	0.000875	0.00383	CcSEcCtD
Ipratropium bromide—Hypoaesthesia—Pravastatin—atherosclerosis	0.000874	0.00383	CcSEcCtD
Ipratropium bromide—Flatulence—Ezetimibe—atherosclerosis	0.000874	0.00383	CcSEcCtD
Ipratropium bromide—Pharyngitis—Pravastatin—atherosclerosis	0.000872	0.00382	CcSEcCtD
Ipratropium bromide—Infection—Rosuvastatin—atherosclerosis	0.000865	0.00379	CcSEcCtD
Ipratropium bromide—Visual impairment—Niacin—atherosclerosis	0.00086	0.00377	CcSEcCtD
Ipratropium bromide—Back pain—Ezetimibe—atherosclerosis	0.000858	0.00376	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000854	0.00374	CcSEcCtD
Ipratropium bromide—Vision blurred—Lovastatin—atherosclerosis	0.000852	0.00373	CcSEcCtD
Ipratropium bromide—Tremor—Lovastatin—atherosclerosis	0.000847	0.00371	CcSEcCtD
Ipratropium bromide—Visual impairment—Pravastatin—atherosclerosis	0.000847	0.00371	CcSEcCtD
Ipratropium bromide—Eye disorder—Niacin—atherosclerosis	0.000834	0.00365	CcSEcCtD
Ipratropium bromide—Flatulence—Simvastatin—atherosclerosis	0.000833	0.00365	CcSEcCtD
Ipratropium bromide—Tinnitus—Niacin—atherosclerosis	0.000832	0.00364	CcSEcCtD
Ipratropium bromide—Dysgeusia—Simvastatin—atherosclerosis	0.000828	0.00363	CcSEcCtD
Ipratropium bromide—Flushing—Niacin—atherosclerosis	0.000828	0.00363	CcSEcCtD
Ipratropium bromide—Angioedema—Lovastatin—atherosclerosis	0.000826	0.00362	CcSEcCtD
Ipratropium bromide—Tinnitus—Pravastatin—atherosclerosis	0.000819	0.00359	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Pravastatin—atherosclerosis	0.000815	0.00357	CcSEcCtD
Ipratropium bromide—Flushing—Pravastatin—atherosclerosis	0.000815	0.00357	CcSEcCtD
Ipratropium bromide—Angioedema—Ezetimibe—atherosclerosis	0.00081	0.00355	CcSEcCtD
Ipratropium bromide—Vision blurred—Simvastatin—atherosclerosis	0.000797	0.00349	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000793	0.00348	CcSEcCtD
Ipratropium bromide—Tremor—Simvastatin—atherosclerosis	0.000792	0.00347	CcSEcCtD
Ipratropium bromide—Insomnia—Rosuvastatin—atherosclerosis	0.000788	0.00345	CcSEcCtD
Ipratropium bromide—Palpitations—Ezetimibe—atherosclerosis	0.000784	0.00343	CcSEcCtD
Ipratropium bromide—Paraesthesia—Rosuvastatin—atherosclerosis	0.000782	0.00343	CcSEcCtD
Ipratropium bromide—Cough—Ezetimibe—atherosclerosis	0.000774	0.00339	CcSEcCtD
Ipratropium bromide—Angioedema—Simvastatin—atherosclerosis	0.000773	0.00339	CcSEcCtD
Ipratropium bromide—Chest pain—Lovastatin—atherosclerosis	0.00077	0.00337	CcSEcCtD
Ipratropium bromide—Myalgia—Lovastatin—atherosclerosis	0.00077	0.00337	CcSEcCtD
Ipratropium bromide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000767	0.00336	CcSEcCtD
Ipratropium bromide—Hypertension—Ezetimibe—atherosclerosis	0.000766	0.00335	CcSEcCtD
Ipratropium bromide—Flatulence—Niacin—atherosclerosis	0.000765	0.00335	CcSEcCtD
Ipratropium bromide—Tension—Niacin—atherosclerosis	0.000762	0.00334	CcSEcCtD
Ipratropium bromide—Chest pain—Ezetimibe—atherosclerosis	0.000755	0.00331	CcSEcCtD
Ipratropium bromide—Myalgia—Ezetimibe—atherosclerosis	0.000755	0.00331	CcSEcCtD
Ipratropium bromide—Nervousness—Niacin—atherosclerosis	0.000754	0.0033	CcSEcCtD
Ipratropium bromide—Flatulence—Pravastatin—atherosclerosis	0.000754	0.0033	CcSEcCtD
Ipratropium bromide—Dry mouth—Lovastatin—atherosclerosis	0.000753	0.0033	CcSEcCtD
Ipratropium bromide—Tension—Pravastatin—atherosclerosis	0.00075	0.00329	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00075	0.00328	CcSEcCtD
Ipratropium bromide—Dysgeusia—Pravastatin—atherosclerosis	0.000749	0.00328	CcSEcCtD
Ipratropium bromide—Constipation—Rosuvastatin—atherosclerosis	0.000745	0.00326	CcSEcCtD
Ipratropium bromide—Pain—Rosuvastatin—atherosclerosis	0.000745	0.00326	CcSEcCtD
Ipratropium bromide—Nervousness—Pravastatin—atherosclerosis	0.000743	0.00325	CcSEcCtD
Ipratropium bromide—Dry mouth—Ezetimibe—atherosclerosis	0.000738	0.00323	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Lovastatin—atherosclerosis	0.000738	0.00323	CcSEcCtD
Ipratropium bromide—Infection—Lovastatin—atherosclerosis	0.000733	0.00321	CcSEcCtD
Ipratropium bromide—Vision blurred—Niacin—atherosclerosis	0.000732	0.00321	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000724	0.00317	CcSEcCtD
Ipratropium bromide—Vision blurred—Pravastatin—atherosclerosis	0.000721	0.00316	CcSEcCtD
Ipratropium bromide—Chest pain—Simvastatin—atherosclerosis	0.00072	0.00315	CcSEcCtD
Ipratropium bromide—Myalgia—Simvastatin—atherosclerosis	0.00072	0.00315	CcSEcCtD
Ipratropium bromide—Infection—Ezetimibe—atherosclerosis	0.000719	0.00315	CcSEcCtD
Ipratropium bromide—Tremor—Pravastatin—atherosclerosis	0.000716	0.00314	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000712	0.00312	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Ezetimibe—atherosclerosis	0.00071	0.00311	CcSEcCtD
Ipratropium bromide—Angioedema—Niacin—atherosclerosis	0.00071	0.00311	CcSEcCtD
Ipratropium bromide—Skin disorder—Ezetimibe—atherosclerosis	0.000703	0.00308	CcSEcCtD
Ipratropium bromide—Angioedema—Pravastatin—atherosclerosis	0.000699	0.00306	CcSEcCtD
Ipratropium bromide—Urticaria—Rosuvastatin—atherosclerosis	0.000692	0.00303	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Simvastatin—atherosclerosis	0.00069	0.00302	CcSEcCtD
Ipratropium bromide—Oedema—Simvastatin—atherosclerosis	0.00069	0.00302	CcSEcCtD
Ipratropium bromide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000688	0.00302	CcSEcCtD
Ipratropium bromide—Palpitations—Niacin—atherosclerosis	0.000686	0.00301	CcSEcCtD
Ipratropium bromide—Infection—Simvastatin—atherosclerosis	0.000686	0.003	CcSEcCtD
Ipratropium bromide—Cough—Niacin—atherosclerosis	0.000678	0.00297	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000672	0.00295	CcSEcCtD
Ipratropium bromide—Insomnia—Lovastatin—atherosclerosis	0.000668	0.00292	CcSEcCtD
Ipratropium bromide—Cough—Pravastatin—atherosclerosis	0.000667	0.00292	CcSEcCtD
Ipratropium bromide—Paraesthesia—Lovastatin—atherosclerosis	0.000663	0.0029	CcSEcCtD
Ipratropium bromide—Myalgia—Niacin—atherosclerosis	0.000661	0.0029	CcSEcCtD
Ipratropium bromide—Hypertension—Pravastatin—atherosclerosis	0.00066	0.00289	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00066	0.00289	CcSEcCtD
Ipratropium bromide—Dyspnoea—Lovastatin—atherosclerosis	0.000658	0.00288	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000657	0.00288	CcSEcCtD
Ipratropium bromide—Insomnia—Ezetimibe—atherosclerosis	0.000655	0.00287	CcSEcCtD
Ipratropium bromide—Chest pain—Pravastatin—atherosclerosis	0.000651	0.00285	CcSEcCtD
Ipratropium bromide—Myalgia—Pravastatin—atherosclerosis	0.000651	0.00285	CcSEcCtD
Ipratropium bromide—Paraesthesia—Ezetimibe—atherosclerosis	0.00065	0.00285	CcSEcCtD
Ipratropium bromide—Dyspepsia—Lovastatin—atherosclerosis	0.00065	0.00285	CcSEcCtD
Ipratropium bromide—Dry mouth—Niacin—atherosclerosis	0.000647	0.00283	CcSEcCtD
Ipratropium bromide—Dyspnoea—Ezetimibe—atherosclerosis	0.000645	0.00283	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000642	0.00281	CcSEcCtD
Ipratropium bromide—Dyspepsia—Ezetimibe—atherosclerosis	0.000637	0.00279	CcSEcCtD
Ipratropium bromide—Fatigue—Lovastatin—atherosclerosis	0.000636	0.00279	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Niacin—atherosclerosis	0.000634	0.00278	CcSEcCtD
Ipratropium bromide—Oedema—Niacin—atherosclerosis	0.000634	0.00278	CcSEcCtD
Ipratropium bromide—Pain—Lovastatin—atherosclerosis	0.000631	0.00276	CcSEcCtD
Ipratropium bromide—Constipation—Lovastatin—atherosclerosis	0.000631	0.00276	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000629	0.00275	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000625	0.00274	CcSEcCtD
Ipratropium bromide—Asthenia—Rosuvastatin—atherosclerosis	0.000625	0.00274	CcSEcCtD
Ipratropium bromide—Insomnia—Simvastatin—atherosclerosis	0.000624	0.00273	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Pravastatin—atherosclerosis	0.000624	0.00273	CcSEcCtD
Ipratropium bromide—Oedema—Pravastatin—atherosclerosis	0.000624	0.00273	CcSEcCtD
Ipratropium bromide—Fatigue—Ezetimibe—atherosclerosis	0.000624	0.00273	CcSEcCtD
Ipratropium bromide—Infection—Pravastatin—atherosclerosis	0.00062	0.00272	CcSEcCtD
Ipratropium bromide—Paraesthesia—Simvastatin—atherosclerosis	0.00062	0.00271	CcSEcCtD
Ipratropium bromide—Pain—Ezetimibe—atherosclerosis	0.000619	0.00271	CcSEcCtD
Ipratropium bromide—Constipation—Ezetimibe—atherosclerosis	0.000619	0.00271	CcSEcCtD
Ipratropium bromide—Tachycardia—Niacin—atherosclerosis	0.000619	0.00271	CcSEcCtD
Ipratropium bromide—Pruritus—Rosuvastatin—atherosclerosis	0.000616	0.0027	CcSEcCtD
Ipratropium bromide—Skin disorder—Niacin—atherosclerosis	0.000616	0.0027	CcSEcCtD
Ipratropium bromide—Dyspnoea—Simvastatin—atherosclerosis	0.000615	0.0027	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Niacin—atherosclerosis	0.000613	0.00268	CcSEcCtD
Ipratropium bromide—Dyspepsia—Simvastatin—atherosclerosis	0.000608	0.00266	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000603	0.00264	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000603	0.00264	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000596	0.00261	CcSEcCtD
Ipratropium bromide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000596	0.00261	CcSEcCtD
Ipratropium bromide—Fatigue—Simvastatin—atherosclerosis	0.000595	0.00261	CcSEcCtD
Ipratropium bromide—Hypotension—Niacin—atherosclerosis	0.000592	0.00259	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000592	0.00259	CcSEcCtD
Ipratropium bromide—Pain—Simvastatin—atherosclerosis	0.00059	0.00259	CcSEcCtD
Ipratropium bromide—Constipation—Simvastatin—atherosclerosis	0.00059	0.00259	CcSEcCtD
Ipratropium bromide—Urticaria—Lovastatin—atherosclerosis	0.000586	0.00257	CcSEcCtD
Ipratropium bromide—Abdominal pain—Lovastatin—atherosclerosis	0.000583	0.00256	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000577	0.00253	CcSEcCtD
Ipratropium bromide—Dizziness—Rosuvastatin—atherosclerosis	0.000576	0.00252	CcSEcCtD
Ipratropium bromide—Urticaria—Ezetimibe—atherosclerosis	0.000575	0.00252	CcSEcCtD
Ipratropium bromide—Insomnia—Niacin—atherosclerosis	0.000573	0.00251	CcSEcCtD
Ipratropium bromide—Abdominal pain—Ezetimibe—atherosclerosis	0.000572	0.00251	CcSEcCtD
Ipratropium bromide—Paraesthesia—Niacin—atherosclerosis	0.000569	0.00249	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000569	0.00249	CcSEcCtD
Ipratropium bromide—Dyspnoea—Niacin—atherosclerosis	0.000565	0.00248	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000564	0.00247	CcSEcCtD
Ipratropium bromide—Insomnia—Pravastatin—atherosclerosis	0.000564	0.00247	CcSEcCtD
Ipratropium bromide—Somnolence—Niacin—atherosclerosis	0.000564	0.00247	CcSEcCtD
Ipratropium bromide—Paraesthesia—Pravastatin—atherosclerosis	0.00056	0.00245	CcSEcCtD
Ipratropium bromide—Dyspepsia—Niacin—atherosclerosis	0.000558	0.00244	CcSEcCtD
Ipratropium bromide—Dyspnoea—Pravastatin—atherosclerosis	0.000556	0.00244	CcSEcCtD
Ipratropium bromide—Dyspepsia—Pravastatin—atherosclerosis	0.000549	0.00241	CcSEcCtD
Ipratropium bromide—Rash—Rosuvastatin—atherosclerosis	0.000549	0.0024	CcSEcCtD
Ipratropium bromide—Dermatitis—Rosuvastatin—atherosclerosis	0.000549	0.0024	CcSEcCtD
Ipratropium bromide—Urticaria—Simvastatin—atherosclerosis	0.000548	0.0024	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Niacin—atherosclerosis	0.000547	0.0024	CcSEcCtD
Ipratropium bromide—Abdominal pain—Simvastatin—atherosclerosis	0.000546	0.00239	CcSEcCtD
Ipratropium bromide—Headache—Rosuvastatin—atherosclerosis	0.000546	0.00239	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Lovastatin—atherosclerosis	0.000544	0.00238	CcSEcCtD
Ipratropium bromide—Pain—Niacin—atherosclerosis	0.000542	0.00237	CcSEcCtD
Ipratropium bromide—Fatigue—Pravastatin—atherosclerosis	0.000538	0.00236	CcSEcCtD
Ipratropium bromide—Constipation—Pravastatin—atherosclerosis	0.000534	0.00234	CcSEcCtD
Ipratropium bromide—Pain—Pravastatin—atherosclerosis	0.000534	0.00234	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000533	0.00234	CcSEcCtD
Ipratropium bromide—Asthenia—Lovastatin—atherosclerosis	0.00053	0.00232	CcSEcCtD
Ipratropium bromide—Pruritus—Lovastatin—atherosclerosis	0.000522	0.00229	CcSEcCtD
Ipratropium bromide—Asthenia—Ezetimibe—atherosclerosis	0.000519	0.00227	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Niacin—atherosclerosis	0.000518	0.00227	CcSEcCtD
Ipratropium bromide—Nausea—Rosuvastatin—atherosclerosis	0.000517	0.00227	CcSEcCtD
Ipratropium bromide—Pruritus—Ezetimibe—atherosclerosis	0.000512	0.00224	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00051	0.00224	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Simvastatin—atherosclerosis	0.000509	0.00223	CcSEcCtD
Ipratropium bromide—Diarrhoea—Lovastatin—atherosclerosis	0.000505	0.00221	CcSEcCtD
Ipratropium bromide—Urticaria—Niacin—atherosclerosis	0.000504	0.00221	CcSEcCtD
Ipratropium bromide—Abdominal pain—Niacin—atherosclerosis	0.000501	0.00219	CcSEcCtD
Ipratropium bromide—Urticaria—Pravastatin—atherosclerosis	0.000496	0.00217	CcSEcCtD
Ipratropium bromide—Asthenia—Simvastatin—atherosclerosis	0.000495	0.00217	CcSEcCtD
Ipratropium bromide—Diarrhoea—Ezetimibe—atherosclerosis	0.000495	0.00217	CcSEcCtD
Ipratropium bromide—Abdominal pain—Pravastatin—atherosclerosis	0.000493	0.00216	CcSEcCtD
Ipratropium bromide—Pruritus—Simvastatin—atherosclerosis	0.000488	0.00214	CcSEcCtD
Ipratropium bromide—Dizziness—Lovastatin—atherosclerosis	0.000488	0.00214	CcSEcCtD
Ipratropium bromide—Dizziness—Ezetimibe—atherosclerosis	0.000479	0.0021	CcSEcCtD
Ipratropium bromide—Diarrhoea—Simvastatin—atherosclerosis	0.000472	0.00207	CcSEcCtD
Ipratropium bromide—Vomiting—Lovastatin—atherosclerosis	0.000469	0.00206	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Niacin—atherosclerosis	0.000467	0.00205	CcSEcCtD
Ipratropium bromide—Rash—Lovastatin—atherosclerosis	0.000465	0.00204	CcSEcCtD
Ipratropium bromide—Dermatitis—Lovastatin—atherosclerosis	0.000465	0.00204	CcSEcCtD
Ipratropium bromide—Headache—Lovastatin—atherosclerosis	0.000462	0.00203	CcSEcCtD
Ipratropium bromide—Vomiting—Ezetimibe—atherosclerosis	0.00046	0.00202	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Pravastatin—atherosclerosis	0.00046	0.00201	CcSEcCtD
Ipratropium bromide—Dizziness—Simvastatin—atherosclerosis	0.000456	0.002	CcSEcCtD
Ipratropium bromide—Rash—Ezetimibe—atherosclerosis	0.000456	0.002	CcSEcCtD
Ipratropium bromide—Dermatitis—Ezetimibe—atherosclerosis	0.000456	0.002	CcSEcCtD
Ipratropium bromide—Asthenia—Niacin—atherosclerosis	0.000455	0.00199	CcSEcCtD
Ipratropium bromide—Headache—Ezetimibe—atherosclerosis	0.000453	0.00199	CcSEcCtD
Ipratropium bromide—Pruritus—Niacin—atherosclerosis	0.000448	0.00196	CcSEcCtD
Ipratropium bromide—Asthenia—Pravastatin—atherosclerosis	0.000448	0.00196	CcSEcCtD
Ipratropium bromide—Pruritus—Pravastatin—atherosclerosis	0.000442	0.00193	CcSEcCtD
Ipratropium bromide—Vomiting—Simvastatin—atherosclerosis	0.000439	0.00192	CcSEcCtD
Ipratropium bromide—Nausea—Lovastatin—atherosclerosis	0.000438	0.00192	CcSEcCtD
Ipratropium bromide—Rash—Simvastatin—atherosclerosis	0.000435	0.00191	CcSEcCtD
Ipratropium bromide—Dermatitis—Simvastatin—atherosclerosis	0.000435	0.0019	CcSEcCtD
Ipratropium bromide—Diarrhoea—Niacin—atherosclerosis	0.000434	0.0019	CcSEcCtD
Ipratropium bromide—Headache—Simvastatin—atherosclerosis	0.000432	0.00189	CcSEcCtD
Ipratropium bromide—Nausea—Ezetimibe—atherosclerosis	0.00043	0.00188	CcSEcCtD
Ipratropium bromide—Diarrhoea—Pravastatin—atherosclerosis	0.000427	0.00187	CcSEcCtD
Ipratropium bromide—Dizziness—Niacin—atherosclerosis	0.000419	0.00184	CcSEcCtD
Ipratropium bromide—Dizziness—Pravastatin—atherosclerosis	0.000413	0.00181	CcSEcCtD
Ipratropium bromide—Nausea—Simvastatin—atherosclerosis	0.00041	0.0018	CcSEcCtD
Ipratropium bromide—Vomiting—Niacin—atherosclerosis	0.000403	0.00177	CcSEcCtD
Ipratropium bromide—Rash—Niacin—atherosclerosis	0.0004	0.00175	CcSEcCtD
Ipratropium bromide—Dermatitis—Niacin—atherosclerosis	0.000399	0.00175	CcSEcCtD
Ipratropium bromide—Headache—Niacin—atherosclerosis	0.000397	0.00174	CcSEcCtD
Ipratropium bromide—Vomiting—Pravastatin—atherosclerosis	0.000397	0.00174	CcSEcCtD
Ipratropium bromide—Rash—Pravastatin—atherosclerosis	0.000394	0.00172	CcSEcCtD
Ipratropium bromide—Dermatitis—Pravastatin—atherosclerosis	0.000393	0.00172	CcSEcCtD
Ipratropium bromide—Headache—Pravastatin—atherosclerosis	0.000391	0.00171	CcSEcCtD
Ipratropium bromide—Nausea—Niacin—atherosclerosis	0.000377	0.00165	CcSEcCtD
Ipratropium bromide—Nausea—Pravastatin—atherosclerosis	0.000371	0.00162	CcSEcCtD
Ipratropium bromide—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.93e-05	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—HMOX1—atherosclerosis	1.92e-05	0.000253	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	1.88e-05	0.000248	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PIK3CG—atherosclerosis	1.88e-05	0.000247	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.86e-05	0.000246	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PIK3CG—atherosclerosis	1.86e-05	0.000245	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOB—atherosclerosis	1.83e-05	0.000242	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PDGFB—atherosclerosis	1.83e-05	0.000241	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—KNG1—atherosclerosis	1.8e-05	0.000237	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—KNG1—atherosclerosis	1.79e-05	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	1.79e-05	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AGT—atherosclerosis	1.79e-05	0.000236	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GSTM1—atherosclerosis	1.78e-05	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGTR1—atherosclerosis	1.78e-05	0.000235	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—KNG1—atherosclerosis	1.77e-05	0.000234	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGTR1—atherosclerosis	1.76e-05	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	1.75e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LCAT—atherosclerosis	1.75e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—FABP4—atherosclerosis	1.75e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—LPL—atherosclerosis	1.75e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—LEP—atherosclerosis	1.75e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—APOE—atherosclerosis	1.75e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCL2—atherosclerosis	1.75e-05	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PLG—atherosclerosis	1.74e-05	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PLG—atherosclerosis	1.74e-05	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CAV1—atherosclerosis	1.73e-05	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCL2—atherosclerosis	1.73e-05	0.000228	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—APOA1—atherosclerosis	1.73e-05	0.000228	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.73e-05	0.000228	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA4—atherosclerosis	1.72e-05	0.000227	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PLG—atherosclerosis	1.72e-05	0.000227	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—LIPC—atherosclerosis	1.72e-05	0.000226	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—GPX1—atherosclerosis	1.71e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOC3—atherosclerosis	1.71e-05	0.000225	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—LDLR—atherosclerosis	1.7e-05	0.000224	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.69e-05	0.000223	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ESR1—atherosclerosis	1.67e-05	0.00022	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CD36—atherosclerosis	1.66e-05	0.00022	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CETP—atherosclerosis	1.66e-05	0.000218	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—F2—atherosclerosis	1.65e-05	0.000218	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	1.65e-05	0.000218	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SOCS3—atherosclerosis	1.64e-05	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SOCS3—atherosclerosis	1.63e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP3—atherosclerosis	1.59e-05	0.00021	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP3—atherosclerosis	1.59e-05	0.000209	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.59e-05	0.000209	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF2—atherosclerosis	1.59e-05	0.000209	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF2—atherosclerosis	1.58e-05	0.000208	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PIK3CG—atherosclerosis	1.58e-05	0.000208	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MTHFR—atherosclerosis	1.58e-05	0.000208	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP3—atherosclerosis	1.57e-05	0.000207	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF2—atherosclerosis	1.56e-05	0.000206	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.56e-05	0.000206	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARA—atherosclerosis	1.55e-05	0.000204	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOB—atherosclerosis	1.54e-05	0.000203	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOB—atherosclerosis	1.53e-05	0.000202	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.53e-05	0.000201	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCL8—atherosclerosis	1.52e-05	0.000201	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOB—atherosclerosis	1.52e-05	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EDN1—atherosclerosis	1.51e-05	0.0002	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—MAPK3—atherosclerosis	1.51e-05	0.000199	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EDN1—atherosclerosis	1.51e-05	0.000199	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCL8—atherosclerosis	1.51e-05	0.000199	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL5—atherosclerosis	1.5e-05	0.000198	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AGT—atherosclerosis	1.5e-05	0.000198	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL5—atherosclerosis	1.5e-05	0.000198	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.5e-05	0.000198	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EDN1—atherosclerosis	1.49e-05	0.000197	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—INS—atherosclerosis	1.49e-05	0.000197	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL5—atherosclerosis	1.48e-05	0.000196	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.48e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.48e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.48e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA2—atherosclerosis	1.48e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCL2—atherosclerosis	1.47e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LPL—atherosclerosis	1.47e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOE—atherosclerosis	1.47e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LPL—atherosclerosis	1.46e-05	0.000193	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.46e-05	0.000193	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CAV1—atherosclerosis	1.45e-05	0.000192	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOA1—atherosclerosis	1.45e-05	0.000191	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LPL—atherosclerosis	1.45e-05	0.000191	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IGF1—atherosclerosis	1.45e-05	0.000191	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	1.43e-05	0.000188	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PRKCG—atherosclerosis	1.42e-05	0.000188	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPA—atherosclerosis	1.41e-05	0.000186	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PRKCG—atherosclerosis	1.41e-05	0.000186	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SPP1—atherosclerosis	1.39e-05	0.000184	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SPP1—atherosclerosis	1.39e-05	0.000183	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.39e-05	0.000183	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCL8—atherosclerosis	1.38e-05	0.000182	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SPP1—atherosclerosis	1.37e-05	0.000181	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SERPINE1—atherosclerosis	1.37e-05	0.000181	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—BGN—atherosclerosis	1.37e-05	0.00018	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCL8—atherosclerosis	1.37e-05	0.00018	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA5—atherosclerosis	1.35e-05	0.000179	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.33e-05	0.000176	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PIK3CG—atherosclerosis	1.33e-05	0.000175	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NOS3—atherosclerosis	1.31e-05	0.000173	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.3e-05	0.000172	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	1.29e-05	0.00017	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PDGFB—atherosclerosis	1.28e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PPARG—atherosclerosis	1.28e-05	0.000169	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PDGFB—atherosclerosis	1.27e-05	0.000168	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.26e-05	0.000166	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AGT—atherosclerosis	1.26e-05	0.000166	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—INS—atherosclerosis	1.25e-05	0.000165	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AGT—atherosclerosis	1.25e-05	0.000165	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AGT—atherosclerosis	1.24e-05	0.000164	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—LEP—atherosclerosis	1.23e-05	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOE—atherosclerosis	1.23e-05	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—LEP—atherosclerosis	1.23e-05	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOE—atherosclerosis	1.23e-05	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CAV1—atherosclerosis	1.22e-05	0.000161	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOA1—atherosclerosis	1.22e-05	0.000161	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CAV1—atherosclerosis	1.22e-05	0.00016	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—LEP—atherosclerosis	1.22e-05	0.00016	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOE—atherosclerosis	1.22e-05	0.00016	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOA1—atherosclerosis	1.21e-05	0.00016	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CAV1—atherosclerosis	1.2e-05	0.000159	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOA1—atherosclerosis	1.2e-05	0.000159	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ESR1—atherosclerosis	1.18e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ESR1—atherosclerosis	1.17e-05	0.000155	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCL8—atherosclerosis	1.16e-05	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—F2—atherosclerosis	1.16e-05	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ESR1—atherosclerosis	1.16e-05	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—F2—atherosclerosis	1.16e-05	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALB—atherosclerosis	1.15e-05	0.000152	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—F2—atherosclerosis	1.15e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.15e-05	0.000151	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.13e-05	0.000149	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—AKT1—atherosclerosis	1.12e-05	0.000148	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LIPC—atherosclerosis	1.12e-05	0.000148	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOC3—atherosclerosis	1.12e-05	0.000147	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.11e-05	0.000147	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LDLR—atherosclerosis	1.11e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PIK3CG—atherosclerosis	1.11e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—atherosclerosis	1.11e-05	0.000146	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—NOS3—atherosclerosis	1.1e-05	0.000145	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PIK3CG—atherosclerosis	1.1e-05	0.000145	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOB—atherosclerosis	1.1e-05	0.000145	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CETP—atherosclerosis	1.08e-05	0.000143	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.07e-05	0.000141	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.06e-05	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—MAPK3—atherosclerosis	1.06e-05	0.00014	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—INS—atherosclerosis	1.05e-05	0.000139	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—atherosclerosis	1.05e-05	0.000139	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—MAPK3—atherosclerosis	1.05e-05	0.000139	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—INS—atherosclerosis	1.05e-05	0.000138	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—LPL—atherosclerosis	1.05e-05	0.000138	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—NFKB1—atherosclerosis	1.04e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—INS—atherosclerosis	1.04e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.04e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL2—atherosclerosis	1.04e-05	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL2—atherosclerosis	1.03e-05	0.000136	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK8—atherosclerosis	1.02e-05	0.000135	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL2—atherosclerosis	1.02e-05	0.000135	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPX1—atherosclerosis	1.02e-05	0.000135	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—AKT1—atherosclerosis	1.02e-05	0.000135	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IGF1—atherosclerosis	1.02e-05	0.000134	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IGF1—atherosclerosis	1.01e-05	0.000134	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—PTGS2—atherosclerosis	1.01e-05	0.000133	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IGF1—atherosclerosis	1e-05	0.000133	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CD36—atherosclerosis	9.95e-06	0.000131	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.79e-06	0.000129	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	9.66e-06	0.000128	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SERPINE1—atherosclerosis	9.63e-06	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SERPINE1—atherosclerosis	9.54e-06	0.000126	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—VEGFA—atherosclerosis	9.44e-06	0.000125	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.43e-06	0.000124	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—STAT3—atherosclerosis	9.35e-06	0.000123	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARA—atherosclerosis	9.25e-06	0.000122	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NOS3—atherosclerosis	9.23e-06	0.000122	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NOS3—atherosclerosis	9.2e-06	0.000121	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NOS3—atherosclerosis	9.11e-06	0.00012	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AGT—atherosclerosis	8.96e-06	0.000118	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK3—atherosclerosis	8.93e-06	0.000118	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOE—atherosclerosis	8.78e-06	0.000116	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.73e-06	0.000115	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CAV1—atherosclerosis	8.7e-06	0.000115	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOA1—atherosclerosis	8.68e-06	0.000115	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFB1—atherosclerosis	8.67e-06	0.000114	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	8.18e-06	0.000108	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL8—atherosclerosis	8.16e-06	0.000108	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	8.08e-06	0.000107	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.92e-06	0.000105	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	7.91e-06	0.000104	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—AKT1—atherosclerosis	7.88e-06	0.000104	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	7.8e-06	0.000103	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—atherosclerosis	7.78e-06	0.000103	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—atherosclerosis	7.76e-06	0.000102	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—atherosclerosis	7.68e-06	0.000101	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PPARG—atherosclerosis	7.65e-06	0.000101	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—INS—atherosclerosis	7.5e-06	9.9e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.49e-06	9.88e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—atherosclerosis	7.4e-06	9.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—atherosclerosis	7.38e-06	9.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	7.32e-06	9.66e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—atherosclerosis	7.31e-06	9.64e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—NFKB1—atherosclerosis	7.3e-06	9.63e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	7.23e-06	9.54e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	7.2e-06	9.5e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	7.18e-06	9.47e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK8—atherosclerosis	7.18e-06	9.47e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOB—atherosclerosis	7.17e-06	9.46e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—AKT1—atherosclerosis	7.16e-06	9.44e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	7.11e-06	9.38e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	7.09e-06	9.35e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.98e-06	9.2e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—atherosclerosis	6.88e-06	9.07e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—LPL—atherosclerosis	6.85e-06	9.03e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPX1—atherosclerosis	6.68e-06	8.81e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	6.65e-06	8.77e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—VEGFA—atherosclerosis	6.63e-06	8.74e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—STAT3—atherosclerosis	6.58e-06	8.68e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—NOS3—atherosclerosis	6.58e-06	8.68e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	6.56e-06	8.66e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—STAT3—atherosclerosis	6.56e-06	8.66e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—atherosclerosis	6.53e-06	8.62e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CD36—atherosclerosis	6.51e-06	8.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—STAT3—atherosclerosis	6.5e-06	8.57e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	6.29e-06	8.3e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK3—atherosclerosis	6.27e-06	8.27e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	6.21e-06	8.19e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.17e-06	8.13e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	6.1e-06	8.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFB1—atherosclerosis	6.08e-06	8.02e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARA—atherosclerosis	6.05e-06	7.98e-05	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—AKT1—atherosclerosis	6.02e-06	7.95e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	6.02e-06	7.95e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.02e-06	7.94e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AGT—atherosclerosis	5.86e-06	7.73e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOE—atherosclerosis	5.74e-06	7.57e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CAV1—atherosclerosis	5.69e-06	7.5e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOA1—atherosclerosis	5.67e-06	7.49e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.18e-06	6.83e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—AKT1—atherosclerosis	5.06e-06	6.67e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PPARG—atherosclerosis	5e-06	6.6e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—INS—atherosclerosis	4.9e-06	6.47e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—atherosclerosis	4.6e-06	6.07e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—atherosclerosis	4.58e-06	6.05e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—atherosclerosis	4.54e-06	5.99e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—atherosclerosis	4.5e-06	5.93e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—NOS3—atherosclerosis	4.3e-06	5.67e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—AKT1—atherosclerosis	4.24e-06	5.6e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—AKT1—atherosclerosis	4.23e-06	5.58e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—AKT1—atherosclerosis	4.19e-06	5.52e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.93e-06	5.19e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—AKT1—atherosclerosis	3.02e-06	3.99e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—AKT1—atherosclerosis	1.98e-06	2.61e-05	CbGpPWpGaD
